Want to join the conversation?
$SYMC 1Q16 PR: Outlook: FY16 revenue to be in the range of $6,210-6,350MM and 2Q16 revenue to be in the range of $1,485-1,525MM; FY16 operating margin to be in the range of 14.5-15.5% and 2Q16 operating margin to be in the range of 13-15%; FY16 diluted EPS to be in the range of $0.86-0.96 and 2Q16 diluted EPS to be in the range of $0.19-0.22.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?